CoChat
Sign Up
Cited by 187

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Research update: Alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease

Parri, H. Rheinallt, Hernandez, Caterina M., Dineley, Kelly T.·2011·Biochemical Pharmacology
DOI 10.1016/j.bcp.2011.06.039
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bcp.2011.06.039

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Flagged first, then by citations

Research works printed but not linked: 125

  1. Hasselmo, 1996, Encoding and retrieval of episodic memories: role of cholinergic and GABAergic modulation in the hippocampus, Hippocampus, 6, 693, 10.1002/(SICI)1098-1063(1996)6:6<693::AID-HIPO12>3.0.CO;2-W · DOI
  2. Hasselmo, 1999, Neuromodulation: acetylcholine and memory consolidation, Trends Cogn Sci, 3, 351, 10.1016/S1364-6613(99)01365-0 · DOI · Paper page
  3. Chrobak, 1988, AF64A-induced working memory impairment: behavioral, neurochemical and histological correlates, Brain Res, 463, 107, 10.1016/0006-8993(88)90532-X · DOI
  4. Olson, 1992, Nerve growth factor affects 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report), J Neural Transm Park Dis Dement Sect, 4, 79, 10.1007/BF02257624 · DOI
  5. Minger, 2000, Cholinergic deficits contribute to behavioral disturbance in patients with dementia, Neurology, 55, 1460, 10.1212/WNL.55.10.1460 · DOI · Paper page
  6. Pappas, 2000, Choline acetyltransferase activity and cognitive domain scores of Alzheimer's patients, Neurobiol Aging, 21, 11, 10.1016/S0197-4580(00)00090-7 · DOI
  7. Doody, 2001, Chronic donepezil treatment is associated with slowed cognitive decline in Alzheimer's disease, Dement Geriatr Cogn Disord, 12, 295, 10.1159/000051272 · DOI · Paper page
  8. Keller, 2011, Long-term effects of galantamine treatment on brain functional activities as measured by PET in Alzheimer's disease patients, J Alzheimers Dis, 24, 109, 10.3233/JAD-2010-101290 · DOI
  9. Ikonomovic, 2009, Cortical alpha7 nicotinic acetylcholine receptor and beta-amyloid levels in early Alzheimer disease, Arch Neurol, 66, 646, 10.1001/archneurol.2009.46 · DOI
  10. Wang, 2009, Dissociating beta-amyloid from alpha7 nicotinic acetylcholine receptor by a novel therapeutic agent, S 24795, normalizes alpha 7 nicotinic acetylcholine and NMDA receptor function in Alzheimer's diseasebrain, J Neurosci, 29, 10961, 10.1523/JNEUROSCI.6088-08.2009 · DOI
  11. Perry, 1987, Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases, J Neurol Neurosurg Psychiatry, 50, 806, 10.1136/jnnp.50.6.806 · DOI
  12. Quirion, 1986, Neurotransmitter and receptor deficits in senile dementia of the Alzheimer type, Can J Neurol Sci, 13, 503, 10.1017/S0317167100037215 · DOI
  13. Fabian-Fine, 2001, Ultrastructural distribution of the alpha7 nicotinic acetylcholine receptor subunit in rat hippocampus, J Neurosci, 21, 7993, 10.1523/JNEUROSCI.21-20-07993.2001 · DOI
  14. Hunt, 1978, The electron microscopic autoradiographic localization of alpha-bungarotoxin binding sites within the central nervous system of the rat, Brain Res, 142, 152, 10.1016/0006-8993(78)90185-3 · DOI
  15. Lilja, 2011, Functional interactions of fibrillar and oligomeric amyloid-beta with alpha7 nicotinic receptors in Alzheimer's disease, J Alzheimers Dis, 23, 335, 10.3233/JAD-2010-101242 · DOI · Paper page
  16. Counts, 2007, Alpha7 nicotinic receptor up-regulation in cholinergic basal forebrain neurons in Alzheimer disease, Arch Neurol, 64, 1771, 10.1001/archneur.64.12.1771 · DOI
  17. Gray, 1996, Hippocampal synaptic transmission enhanced by low concentrations of nicotine, Nature, 383, 713, 10.1038/383713a0 · DOI
  18. Ji, 2001, Timing and location of nicotinic activity enhances or depresses hippocampal synaptic plasticity, Neuron, 31, 131, 10.1016/S0896-6273(01)00332-4 · DOI · Paper page
  19. Dani, 2001, Nicotinic receptor activity alters synaptic plasticity, Sci World J, 1, 393, 10.1100/tsw.2001.74 · DOI
  20. Rezvani, 2002, Effects of nicotine and mecamylamine on choice accuracy in an operant visual signal detection task in female rats, Psychopharmacology (Berl)., 164, 369, 10.1007/s00213-002-1221-0 · DOI
  21. Levin, 2002, Nicotinic treatment for cognitive dysfunction, Curr Drug Targets CNS Neurol Disord, 1, 423, 10.2174/1568007023339102 · DOI
  22. Wilson, 1995, Nicotine patches in Alzheimer's disease: pilot study on learning, memory, and safety, Pharmacol Biochem Behav, 51, 509, 10.1016/0091-3057(95)00043-V · DOI
  23. Lopez-Arrieta, 2000, Nicotine for Alzheimer's disease, Cochrane Database Syst Rev, CD001749
  24. Zamani, 2001, Nicotine and its interaction with beta-amyloid protein: a short review, Biol Psychiatry, 49, 221, 10.1016/S0006-3223(00)01108-2 · DOI
  25. Lopez-Arrieta, 2001, Efficacy and safety of nicotine on Alzheimer's disease patients, Cochrane Database Syst Rev, CD001749
  26. O’Neill, 2002, The role of neuronal nicotinic acetylcholine receptors in acute and chronic neurodegeneration, Curr Drug Targets CNS Neurol Disord, 1, 399, 10.2174/1568007023339166 · DOI
  27. Wang, 2000, Beta-amyloid (1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology, J Biol Chem, 275, 5626, 10.1074/jbc.275.8.5626 · DOI
  28. Wang, 2000, Amyloid peptide abeta (1-42) binds selectively and with picomolar affinity to alpha7 nicotinic acetylcholine receptors, J Neurochem, 75, 1155, 10.1046/j.1471-4159.2000.0751155.x · DOI
  29. Dineley, 2007, Beta-amyloid peptide – nicotinic acetylcholine receptor interaction: the two faces of health and disease, Front Biosci, 12, 5030, 10.2741/2445 · DOI
  30. Parri, 2008, Nicotinic acetylcholine receptor interaction with beta-amyloid: molecular, cellular, and physiological consequences, Curr Alzheimer Res, 7, 27, 10.2174/156720510790274464 · DOI
  31. Li SF, Wu MN, Wang XH, Yuan L, Yang D, Qi JS. Alpha7 nicotinic acetylcholine receptors are required for Abeta-induced depression of hippocampal LTP in CA1 region of rats in vivo. Synapse; May 16 2011. · DOI
  32. Cleary, 2005, Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function, Nat Neurosci, 8, 79, 10.1038/nn1372 · DOI
  33. Chen, 2006, Alpha7 nicotinic acetylcholine receptor as a target to rescue deficit in hippocampal LTP induction in beta-amyloid infused rats, Neuropharmacology, 50, 254, 10.1016/j.neuropharm.2005.09.018 · DOI
  34. Puzzo, 2010, Endogenous amyloid-beta is necessary for hippocampal synaptic plasticity and memory, Ann Neurol, 69, 819, 10.1002/ana.22313 · DOI · Paper page
  35. Bell, 2004, MAPK recruitment by beta-amyloid in organotypic hippocampal slice cultures depends on physical state and exposure time, J Neurochem, 91, 349, 10.1111/j.1471-4159.2004.02722.x · DOI
  36. Young, 2009, Oligomeric aggregates of amyloid beta peptide 1-42 activate ERK/MAPK in SH-SY5Y cells via the alpha7 nicotinic receptor, Neurochem Int, 55, 796, 10.1016/j.neuint.2009.08.002 · DOI
  37. Gu, 2011, Timing-dependent septal cholinergic induction of dynamic hippocampal synaptic plasticity, Neuron, 71, 155, 10.1016/j.neuron.2011.04.026 · DOI
  38. Nagele, 2002, Intracellular accumulation of beta-amyloid (1-42) in neurons is facilitated by the alpha 7 nicotinic acetylcholine receptor in Alzheimer's disease, Neuroscience, 110, 199, 10.1016/S0306-4522(01)00460-2 · DOI
  39. Wang, 2010, S 24795 limits beta-amyloid-alpha7 nicotinic receptor interaction and reduces Alzheimer's disease-like pathologies, Biol Psychiatry, 67, 522, 10.1016/j.biopsych.2009.09.031 · DOI
  40. Espinoza-Fonseca, 2004, Base docking model of the homomeric alpha7 nicotinic receptor-beta-amyloid (1-42) complex, Biochem Biophys Res Commun, 320, 587, 10.1016/j.bbrc.2004.05.207 · DOI
  41. Brejc, 2001, Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors, Nature, 411, 269, 10.1038/35077011 · DOI
  42. Wang, 2003, Alpha 7 nicotinic acetylcholine receptors mediate beta-amyloid peptide-induced tau protein phosphorylation, J Biol Chem, 278, 31547, 10.1074/jbc.M212532200 · DOI
  43. Kuo, 1996, Water-soluble abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains, J Biol Chem, 271, 4077, 10.1074/jbc.271.8.4077 · DOI · Paper page
  44. Andreasen, 2003, Cerebrospinal fluid levels of total-tau, phospho-tau and A beta 42 predicts development of Alzheimer's disease in patients with mild cognitive impairment, Acta Neurol Scand Suppl, 179, 47, 10.1034/j.1600-0404.107.s179.9.x · DOI
  45. Tapiola, 2000, Three-year follow-up of cerebrospinal fluid tau, beta-amyloid 42 and 40 concentrations in Alzheimer's disease, Neurosci Lett, 280, 119, 10.1016/S0304-3940(00)00767-9 · DOI
  46. Khan, 2010, Beta-amyloid activates presynaptic alpha7 nicotinic acetylcholine receptors reconstituted into a model nerve cell system: involvement of lipid rafts, Eur J Neurosci, 31, 788, 10.1111/j.1460-9568.2010.07116.x · DOI
  47. Dineley, 2001, Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: in vitro and in vivo mechanisms related to Alzheimer's disease, J Neurosci, 21, 4125, 10.1523/JNEUROSCI.21-12-04125.2001 · DOI · Paper page
  48. Wu, 2007, Dopamine release in prefrontal cortex in response to beta-amyloid activation of alpha7* nicotinic receptors, Brain Res, 1182, 82, 10.1016/j.brainres.2007.08.079 · DOI
  49. Dougherty, 2003, Beta-amyloid regulation of presynaptic nicotinic receptors in rat hippocampus and neocortex, J Neurosci, 23, 6740, 10.1523/JNEUROSCI.23-17-06740.2003 · DOI
  50. Khan, 2003, Beta-amyloid activates presynaptic alpha7 nicotinic acetylcholine receptors reconstituted into a model nerve cell system: involvement of lipid rafts, Eur J Neurosci, 31, 788, 10.1111/j.1460-9568.2010.07116.x · DOI
  51. Dineley, 2002, Beta-amyloid peptide activates alpha 7 nicotinic acetylcholine receptors expressed in Xenopus oocytes, J Biol Chem, 277, 25056, 10.1074/jbc.M200066200 · DOI
  52. Grassi, 2003, Amyloid beta (1-42) peptide alters the gating of human and mouse alpha-bungarotoxin-sensitive nicotinic receptors, J Physiol, 547, 147, 10.1113/jphysiol.2002.035436 · DOI
  53. Liu, 2001, Beta-amyloid peptide blocks the response of alpha 7-containing nicotinic receptors on hippocampal neurons, Proc Natl Acad Sci USA, 98, 4734, 10.1073/pnas.081553598 · DOI
  54. Lamb, 2005, Inhibition of neuronal nicotinic acetylcholine receptor channels expressed in Xenopus oocytes by beta-amyloid1-42 peptide, J Mol Neurosci, 27, 13, 10.1385/JMN:27:1:013 · DOI
  55. Pym, 2005, Subtype-specific actions of beta-amyloid peptides on recombinant human neuronal nicotinic acetylcholine receptors (alpha7, alpha4beta2, alpha3beta4) expressed in Xenopus laevis oocytes, Br J Pharmacol, 146, 964, 10.1038/sj.bjp.0706403 · DOI
  56. Young, 2008, Potentiation of alpha7 nicotinic acetylcholine receptors via an allosteric transmembrane site, Proc Natl Acad Sci USA, 105, 14686, 10.1073/pnas.0804372105 · DOI
  57. Gill, 2011, Agonist activation of {alpha}7 nicotinic acetylcholine receptors via an allosteric transmembrane site, Proc Natl Acad Sci USA, 108, 5867, 10.1073/pnas.1017975108 · DOI
  58. Gill, 2011, Agonist activation of {alpha}7 nicotinic acetylcholine receptors via an allosteric transmembrane site, Proc Natl Acad Sci USA, 108, 5867, 10.1073/pnas.1017975108 · DOI
  59. Pandya, 2011, Allosteric modulator desformylflustrabromine relieves the inhibition of alpha2beta2 and alpha4beta2 nicotinic acetylcholine receptors by beta-amyloid (1-42) peptide, J Mol Neurosci, 10.1007/s12031-011-9509-3 · DOI
  60. Barrantes, 2010, Boundary lipids in the nicotinic acetylcholine receptor microenvironment, J Mol Neurosci, 40, 87, 10.1007/s12031-009-9262-z · DOI
  61. Alexander, 2011, Palmitoylation of nicotinic acetylcholine receptors, J Mol Neurosci, 40, 12
  62. Govind, 2009, Nicotine-induced upregulation of nicotinic receptors: underlying mechanisms and relevance to nicotine addiction, Biochem Pharmacol, 78, 756, 10.1016/j.bcp.2009.06.011 · DOI · Paper page
  63. Dani, 2007, Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system, Annu Rev Pharmacol Toxicol, 47, 699, 10.1146/annurev.pharmtox.47.120505.105214 · DOI · Paper page
  64. Pettit, 2001, Beta-amyloid (1-42) peptide directly modulates nicotinic receptors in the rat hippocampal slice, J Neurosci, 21, RC120, 10.1523/JNEUROSCI.21-01-j0003.2001 · DOI
  65. Krashia, 2010, Human alpha3beta4 neuronal nicotinic receptors show different stoichiometry if they are expressed in Xenopus oocytes or mammalian HEK293 cells, PLoS One, 5, e13611, 10.1371/journal.pone.0013611 · DOI
  66. Malysz, 2010, In vitro pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107, J Pharmacol Exp Ther, 334, 863, 10.1124/jpet.110.167072 · DOI · Paper page
  67. Liu, 2009, A novel nicotinic acetylcholine receptor subtype in basal forebrain cholinergic neurons with high sensitivity to amyloid peptides, J Neurosci, 29, 918, 10.1523/JNEUROSCI.3952-08.2009 · DOI
  68. Wu, 2004, Beta-amyloid directly inhibits human alpha4beta2-nicotinic acetylcholine receptors heterologously expressed in human SH-EP1 cells, J Biol Chem, 279, 37842, 10.1074/jbc.M400335200 · DOI
  69. Mehta, 2009, Defining pre-synaptic nicotinic receptors regulated by beta amyloid in mouse cortex and hippocampus with receptor null mutants, J Neurochem, 109, 1452, 10.1111/j.1471-4159.2009.06070.x · DOI
  70. Barrantes, 2007, Cholesterol effects on nicotinic acetylcholine receptor, J Neurochem, 103, 72, 10.1111/j.1471-4159.2007.04719.x · DOI
  71. Bermudez, 2010, Partition profile of the nicotinic acetylcholine receptor in lipid domains upon reconstitution, J Lipid Res, 51, 2629, 10.1194/jlr.M005132 · DOI
  72. Abbott, 2008, Abeta (1-42) modulation of Akt phosphorylation via alpha7 nAChR and NMDA receptors, Neurobiol Aging, 29, 992, 10.1016/j.neurobiolaging.2007.01.003 · DOI
  73. Horwood, 2006, Signalling mechanisms mediated by the phosphoinositide 3-kinase/Akt cascade in synaptic plasticity and memory in the rat, Eur J Neurosci, 23, 3375, 10.1111/j.1460-9568.2006.04859.x · DOI
  74. Kihara, 2001, Alpha 7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A beta-amyloid-induced neurotoxicity, J Biol Chem, 276, 13541, 10.1074/jbc.M008035200 · DOI
  75. Zanardi, 2002, Nicotine and neurodegeneration in ageing, Toxicol Lett, 127, 207, 10.1016/S0378-4274(01)00502-1 · DOI
  76. Shaw, 2002, Janus kinase 2, an early target of alpha 7 nicotinic acetylcholine receptor-mediated neuroprotection against abeta- (1-42) amyloid, J Biol Chem, 277, 44920, 10.1074/jbc.M204610200 · DOI
  77. Naslund, 1994, Relative abundance of Alzheimer A beta amyloid peptide variants in Alzheimer disease and normal aging, Proc Natl Acad Sci USA, 91, 8378, 10.1073/pnas.91.18.8378 · DOI · Paper page
  78. Plant, 2003, The production of amyloid beta peptide is a critical requirement for the viability of central neurons, J Neurosci, 23, 5531, 10.1523/JNEUROSCI.23-13-05531.2003 · DOI
  79. Sharma, 2001, Nicotinic cholinergic signaling in hippocampal astrocytes involves calcium-induced calcium release from intracellular stores, Proc Natl Acad Sci USA, 98, 4148, 10.1073/pnas.071540198 · DOI
  80. Shytle, 2004, Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors, J Neurochem, 89, 337, 10.1046/j.1471-4159.2004.02347.x · DOI
  81. Volterra, 2005, Astrocytes, from brain glue to communication elements: the revolution continues, Nat Rev Neurosci, 6, 626, 10.1038/nrn1722 · DOI
  82. Wonnacott, 2008, Gates and filters: unveiling the physiological roles of nicotinic acetylcholine receptors in dopaminergic transmission, Br J Pharmacol, 153, S2, 10.1038/sj.bjp.0707583 · DOI
  83. Zoli, 1998, Identification of four classes of brain nicotinic receptors using beta2 mutant mice, J Neurosci, 18, 4461, 10.1523/JNEUROSCI.18-12-04461.1998 · DOI
  84. Picciotto, 1998, Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine, Nature, 391, 173, 10.1038/34413 · DOI · Paper page
  85. Orr-Urtreger, 1997, Mice deficient in the alpha7 neuronal nicotinic acetylcholine receptor lack alpha-bungarotoxin binding sites and hippocampal fast nicotinic currents, J Neurosci, 17, 9165, 10.1523/JNEUROSCI.17-23-09165.1997 · DOI
  86. Chen, 2010, DMXB (GTS-21) ameliorates the cognitive deficits in beta amyloid (25-35(−)) injected mice through preventing the dysfunction of alpha7 nicotinic receptor, J Neurosci Res, 88, 1784, 10.1002/jnr.22345 · DOI
  87. Kem, 1997, Anabaseine is a potent agonist on muscle and neuronal alpha-bungarotoxin-sensitive nicotinic receptors, J Pharmacol Exp Ther, 283, 979, 10.1016/S0022-3565(24)37134-4 · DOI
  88. Jourdain, 2007, Glutamate exocytosis from astrocytes controls synaptic strength, Nat Neurosci, 10, 331, 10.1038/nn1849 · DOI
  89. Araque, 2002, Synaptically released acetylcholine evokes Ca2+ elevations in astrocytes in hippocampal slices, J Neurosci, 22, 2443, 10.1523/JNEUROSCI.22-07-02443.2002 · DOI · Paper page
  90. Kang, 1998, Astrocyte-mediated potentiation of inhibitory synaptic transmission, Nat Neurosci, 1, 683, 10.1038/3684 · DOI
  91. King, 1996, P2 purinoceptors in rat cortical astrocytes: expression, calcium-imaging and signalling studies, Neuroscience, 74, 1187, 10.1016/0306-4522(96)00209-6 · DOI
  92. Porter, 1996, Hippocampal astrocytes in situ respond to glutamate released from synaptic terminals, J Neurosci, 16, 5073, 10.1523/JNEUROSCI.16-16-05073.1996 · DOI
  93. Velez-Fort, 2009, Functional alpha 7-containing nicotinic receptors of NG2-expressing cells in the hippocampus, Glia, 57, 1104, 10.1002/glia.20834 · DOI
  94. Kihara, 1997, Nicotinic receptor stimulation protects neurons against beta-amyloid toxicity, Ann Neurol, 42, 159, 10.1002/ana.410420205 · DOI
  95. Jonnala, 2001, Relationship between the increased cell surface alpha7 nicotinic receptor expression and neuroprotection induced by several nicotinic receptor agonists, J Neurosci Res, 66, 565, 10.1002/jnr.10022 · DOI
  96. Takeuchi, 2000, Age-related amyloid beta deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss, Am J Pathol, 157, 331, 10.1016/S0002-9440(10)64544-0 · DOI · Paper page
  97. Jones, 2006, Alpha7 nicotinic acetylcholine receptor expression in Alzheimer's disease: receptor densities in brain regions of the APP (SWE) mouse model and in human peripheral blood lymphocytes, J Mol Neurosci, 30, 83, 10.1385/JMN:30:1:83 · DOI
  98. Bednar, 2002, Selective nicotinic receptor consequences in APP (SWE) transgenic mice, Mol Cell Neurosci, 20, 354, 10.1006/mcne.2002.1112 · DOI
  99. Takada-Takatori, 2006, Acetylcholinesterase inhibitors used in treatment of Alzheimer's disease prevent glutamate neurotoxicity via nicotinic acetylcholine receptors and phosphatidylinositol 3-kinase cascade, Neuropharmacology, 51, 474, 10.1016/j.neuropharm.2006.04.007 · DOI
  100. Li, 2003, Effect of beta-amyloid peptide 1-42 on the cytoprotective action mediated by alpha7 nicotinic acetylcholine receptors in growth factor-deprived differentiated PC-12 cells, J Pharmacol Exp Ther, 307, 670, 10.1124/jpet.103.053785 · DOI
  101. Li, 2005, Effect of amyloid peptides on the increase in TrkA receptor expression induced by nicotine in vitro and in vivo, J Mol Neurosci, 27, 325, 10.1385/JMN:27:3:325 · DOI
  102. Hernandez, 2005, Repeated nicotine exposure in rats: effects on memory function, cholinergic markers and nerve growth factor, Neuroscience, 130, 997, 10.1016/j.neuroscience.2004.10.006 · DOI
  103. Barrantes, 1995, Alpha-bungarotoxin binding sites in rat hippocampal and cortical cultures: initial characterisation, colocalisation with alpha 7 subunits and up-regulation by chronic nicotine treatment, Brain Res, 672, 228, 10.1016/0006-8993(94)01386-V · DOI
  104. Glabe, 2006, Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis, Neurology, 66, S74, 10.1212/01.wnl.0000192103.24796.42 · DOI
  105. Westerman, 2002, The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease, J Neurosci, 22, 1858, 10.1523/JNEUROSCI.22-05-01858.2002 · DOI
  106. Dineley, 2010, Amyloid-beta oligomers impair fear conditioned memory in a calcineurin-dependent fashion in mice, J Neurosci Res, 88, 2923, 10.1002/jnr.22445 · DOI
  107. Akiyama, 1999, Occurrence of the diffuse amyloid beta-protein (Abeta) deposits with numerous Abeta-containing glial cells in the cerebral cortex of patients with Alzheimer's disease, Glia, 25, 324, 10.1002/(SICI)1098-1136(19990215)25:4<324::AID-GLIA2>3.0.CO;2-5 · DOI
  108. D’Andrea, 2002, Consistent immunohistochemical detection of intracellular beta-amyloid42 in pyramidal neurons of Alzheimer's disease entorhinal cortex, Neurosci Lett, 333, 163, 10.1016/S0304-3940(02)00875-3 · DOI · Paper page
  109. Nagele, 2003, Astrocytes accumulate A beta 42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains, Brain Res, 971, 197, 10.1016/S0006-8993(03)02361-8 · DOI · Paper page
  110. Wang, 2002, Cerebellar diffuse amyloid plaques are derived from dendritic Abeta42 accumulations in Purkinje cells, Neurobiol Aging, 23, 213, 10.1016/S0197-4580(01)00279-2 · DOI
  111. Nagele, 2004, Contribution of glial cells to the development of amyloid plaques in Alzheimer's disease, Neurobiol Aging, 25, 663, 10.1016/j.neurobiolaging.2004.01.007 · DOI
  112. Teaktong, 2004, Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: differential neuronal and astroglial pathology, J Neurol Sci, 225, 39, 10.1016/j.jns.2004.06.015 · DOI
  113. Moser, 2007, Evaluating the suitability of nicotinic acetylcholine receptor antibodies for standard immunodetection procedures, J Neurochem, 102, 479, 10.1111/j.1471-4159.2007.04498.x · DOI
  114. Yu, 2005, High selective expression of alpha7 nicotinic receptors on astrocytes in the brains of patients with sporadic Alzheimer's disease and patients carrying Swedish APP 670/671 mutation: a possible association with neuritic plaques, Exp Neurol, 192, 215, 10.1016/j.expneurol.2004.12.015 · DOI
  115. Xiu, 2005, Expression of nicotinic receptors on primary cultures of rat astrocytes and up-regulation of the alpha7, alpha4 and beta2 subunits in response to nanomolar concentrations of the beta-amyloid peptide (1-42), Neurochem Int, 47, 281, 10.1016/j.neuint.2005.04.023 · DOI
  116. Paylor, 1998, Alpha7 nicotinic receptor subunits are not necessary for hippocampal-dependent learning or sensorimotor gating: a behavioral characterization of Acra7-deficient mice, Learn Mem, 5, 302, 10.1101/lm.5.4.302 · DOI · Paper page
  117. Hellstrom-Lindahl, 1999, Regional distribution of nicotinic receptor subunit mRNAs in human brain: comparison between Alzheimer and normal brain, Brain Res Mol Brain Res, 66, 94, 10.1016/S0169-328X(99)00030-3 · DOI
  118. Ren, 2007, The alpha7 nicotinic receptor agonist 4OH-GTS-21 protects axotomized septo-hippocampal cholinergic neurons in wild-type but not amyloid-overexpressing transgenic mice, Neuroscience, 148, 230, 10.1016/j.neuroscience.2007.05.013 · DOI
  119. Soderman, 2008, The nicotinic alpha7 acetylcholine receptor agonist ssr 180711 is unable to activate limbic neuronsin mice overexpressing human amyloid-beta1-42, Brain Res, 1227, 240, 10.1016/j.brainres.2008.06.062 · DOI
  120. Walsh, 2005, The role of cell-derived oligomers of Abeta in Alzheimer's disease and avenues for therapeutic intervention, Biochem Soc Trans, 33, 1087, 10.1042/BST0331087 · DOI
  121. Gopalakrishnan, 2011, Functional characterization and high-throughput screening of positive allosteric modulators of alpha7 nicotinic acetylcholine receptors in IMR-32 neuroblastoma cells, Assay Drug Dev Technol, 10.1089/adt.2010.0319 · DOI
  122. Hu, 2009, Positive allosteric modulation of alpha7 neuronal nicotinic acetylcholine receptors: lack of cytotoxicity in PC12 cells and rat primary cortical neurons, Br J Pharmacol, 158, 1857, 10.1111/j.1476-5381.2009.00474.x · DOI
  123. Williams, 2011, Positive allosteric modulators as an approach to nicotinic acetylcholine receptor-targeted therapeutics: advantages and limitations, Biochem Pharmacol, 82, 915, 10.1016/j.bcp.2011.05.001 · DOI
  124. Editorial, State of Aggregation Nat Neurosci. 2011 14(4):399-399, doi:1097-6256.
  125. Parri HR, Dineley KT, Beta-amyloid effects on astrocytic activity in an APP overexpressing mouse Tg2576. Nicotinic Acetylcholine Receptors 2011, a Wellcome Trust scientific conference.

Cited by

Sorted by citations

Metadata

Authors
Parri, H. R., Hernandez, C. M., & Dineley, K. T.
Venue
Biochemical Pharmacology
Publisher
Elsevier BV
Published
2011-10
Volume
82
Issue
8
Pages
931-942
ISSN
0006-2952
DOI
10.1016/j.bcp.2011.06.039
Cited by
187
References
17
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review